Cookie Consent by FreePrivacyPolicy.com
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Mission 2024:

Genekam making ready
for Nasdaq IPO 2024

BIO CEO & Investor Conference in New York (26 and 27.2.2024)

The results of the above conference are as follows: 17 meetings were confirmed. 14 meetings with investment banks and investors took place. Now we have to do the follow up these meeting with investment banks and investors to see the final results.

  • EUDAMED

    A number of Genekam products are registered with EUDAMED
    A step towards meeting the lastest IVDR requirements

  • LSX World conference

    Genekam is to attend LSX World conference 29-30 April, 2024, Business Design Center, London, UK

  • MEDICA 2024

    Visit us on Medica Duesseldorf, 11.-14. November 2024

++++++++ Notice: We are uploading a new website with better security. If you get any problem with this website, please send us email: anfrage@genekam.de ++++++++

Products

TOP